Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions

C. De Cicco, G. Trifirò, M. Intra, G. Marotta, A. Ciprian, A. Frasson, G. Prisco, A. Luini, G. Viale, G. Paganelli

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The aim of this study was to evaluate the feasibility of sentinel node (SN) biopsy in occult breast lesions with different radiopharmaceuticals and to establish the optimal lymphoscintigraphic method to detect both occult lesions and SNs (SNOLL: sentinel node and occult lesion localisation). Two hundred and twenty-seven consecutive patients suspected to have clinically occult breast carcinoma were enrolled in the study. In addition to the radioguided occult lesion localisation (ROLL) procedure, using macroaggregates of technetium-99m labelled human serum albumin (MAA) injected directly into the lesion, lymphoscintigraphy was performed with nanocolloids (NC) injected in a peritumoral (group I) or a subdermal site (group II). In group III, a sole injection of NC was done into the lesion in order to perform both ROLL and SNOLL. Overall, axillary SNs were identified in 205 of the 227 patients (90.3%). In 12/62 (19.4%) patients of group I and 9/79 (11.4%) patients of group III, radioactive nodes were not visualised, whereas SNs were successfully localised in 85 of 86 patients of group II (P

Original languageEnglish
Pages (from-to)349-354
Number of pages6
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume31
Issue number3
DOIs
Publication statusPublished - Mar 2004

Fingerprint

Nuclear Medicine
Breast
Neoplasms
Lymphoscintigraphy
Radiopharmaceuticals
Technetium
Serum Albumin
cyhalothrin
Breast Neoplasms
Biopsy
Injections

Keywords

  • Breast neoplasms
  • Lymphoscintigraphy
  • Non-palpable lesion
  • Radionuclide imaging
  • Sentinel node

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

@article{5ce40bb253fc43168b8aeb91c0288fd1,
title = "Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions",
abstract = "The aim of this study was to evaluate the feasibility of sentinel node (SN) biopsy in occult breast lesions with different radiopharmaceuticals and to establish the optimal lymphoscintigraphic method to detect both occult lesions and SNs (SNOLL: sentinel node and occult lesion localisation). Two hundred and twenty-seven consecutive patients suspected to have clinically occult breast carcinoma were enrolled in the study. In addition to the radioguided occult lesion localisation (ROLL) procedure, using macroaggregates of technetium-99m labelled human serum albumin (MAA) injected directly into the lesion, lymphoscintigraphy was performed with nanocolloids (NC) injected in a peritumoral (group I) or a subdermal site (group II). In group III, a sole injection of NC was done into the lesion in order to perform both ROLL and SNOLL. Overall, axillary SNs were identified in 205 of the 227 patients (90.3{\%}). In 12/62 (19.4{\%}) patients of group I and 9/79 (11.4{\%}) patients of group III, radioactive nodes were not visualised, whereas SNs were successfully localised in 85 of 86 patients of group II (P",
keywords = "Breast neoplasms, Lymphoscintigraphy, Non-palpable lesion, Radionuclide imaging, Sentinel node",
author = "{De Cicco}, C. and G. Trifir{\`o} and M. Intra and G. Marotta and A. Ciprian and A. Frasson and G. Prisco and A. Luini and G. Viale and G. Paganelli",
year = "2004",
month = "3",
doi = "10.1007/s00259-003-1390-z",
language = "English",
volume = "31",
pages = "349--354",
journal = "European Journal of Pediatrics",
issn = "0340-6199",
publisher = "Springer Berlin Heidelberg",
number = "3",

}

TY - JOUR

T1 - Optimised nuclear medicine method for tumour marking and sentinel node detection in occult primary breast lesions

AU - De Cicco, C.

AU - Trifirò, G.

AU - Intra, M.

AU - Marotta, G.

AU - Ciprian, A.

AU - Frasson, A.

AU - Prisco, G.

AU - Luini, A.

AU - Viale, G.

AU - Paganelli, G.

PY - 2004/3

Y1 - 2004/3

N2 - The aim of this study was to evaluate the feasibility of sentinel node (SN) biopsy in occult breast lesions with different radiopharmaceuticals and to establish the optimal lymphoscintigraphic method to detect both occult lesions and SNs (SNOLL: sentinel node and occult lesion localisation). Two hundred and twenty-seven consecutive patients suspected to have clinically occult breast carcinoma were enrolled in the study. In addition to the radioguided occult lesion localisation (ROLL) procedure, using macroaggregates of technetium-99m labelled human serum albumin (MAA) injected directly into the lesion, lymphoscintigraphy was performed with nanocolloids (NC) injected in a peritumoral (group I) or a subdermal site (group II). In group III, a sole injection of NC was done into the lesion in order to perform both ROLL and SNOLL. Overall, axillary SNs were identified in 205 of the 227 patients (90.3%). In 12/62 (19.4%) patients of group I and 9/79 (11.4%) patients of group III, radioactive nodes were not visualised, whereas SNs were successfully localised in 85 of 86 patients of group II (P

AB - The aim of this study was to evaluate the feasibility of sentinel node (SN) biopsy in occult breast lesions with different radiopharmaceuticals and to establish the optimal lymphoscintigraphic method to detect both occult lesions and SNs (SNOLL: sentinel node and occult lesion localisation). Two hundred and twenty-seven consecutive patients suspected to have clinically occult breast carcinoma were enrolled in the study. In addition to the radioguided occult lesion localisation (ROLL) procedure, using macroaggregates of technetium-99m labelled human serum albumin (MAA) injected directly into the lesion, lymphoscintigraphy was performed with nanocolloids (NC) injected in a peritumoral (group I) or a subdermal site (group II). In group III, a sole injection of NC was done into the lesion in order to perform both ROLL and SNOLL. Overall, axillary SNs were identified in 205 of the 227 patients (90.3%). In 12/62 (19.4%) patients of group I and 9/79 (11.4%) patients of group III, radioactive nodes were not visualised, whereas SNs were successfully localised in 85 of 86 patients of group II (P

KW - Breast neoplasms

KW - Lymphoscintigraphy

KW - Non-palpable lesion

KW - Radionuclide imaging

KW - Sentinel node

UR - http://www.scopus.com/inward/record.url?scp=12144290010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12144290010&partnerID=8YFLogxK

U2 - 10.1007/s00259-003-1390-z

DO - 10.1007/s00259-003-1390-z

M3 - Article

C2 - 14647985

AN - SCOPUS:12144290010

VL - 31

SP - 349

EP - 354

JO - European Journal of Pediatrics

JF - European Journal of Pediatrics

SN - 0340-6199

IS - 3

ER -